Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sakura Finetek
Chuo-ku, Tokyo, Japansakura-finetek.com ↗
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Commercial
01
Overview
Sakura Finetek develops and manufactures automated instruments, consumables, reagents, and antibodies primarily for anatomic pathology laboratories. Their products are industry standards in tissue processing, embedding, staining, coverslipping, and digital imaging. The company does not develop therapeutics or conduct clinical trials but supports cancer diagnosis through advanced automation of laboratory workflows.
- Therapeutic areas
- OncologyOther
- Modalities
- DeviceReagentAntibodyProbe
- Industry
- Pathology
02
Partnerships
Historical partnerships with Miles-Sankyo Co.Medscand ABongoing collaborations with distributors/OEM partners globally
Beyond the preview
Go deeper on Sakura Finetek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sakura Finetek.